Issn Print: 0923-7534
Publication Date: 2017/12/18
The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC
P N Aguiar; L A Perry; J Penny-Dimri; H Babiker; H Tadokoro; R A de Mello; G L Lopes
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.